Literature DB >> 3512612

Cyclosporin and renal graft histology.

A J d'Ardenne, M S Dunnill, J F Thompson, D McWhinnie, R F Wood, P J Morris.   

Abstract

The histology of renal allografts was compared in a series of 107 biopsies from patients receiving cyclosporin and 126 biopsies from patients receiving azathioprine and prednisolone. Patients receiving cyclosporin were converted to azathioprine and prednisolone 90 days after transplantation. Biopsies were taken routinely at 7, 21, 90, and 365 days, irrespective of clinical graft function and were examined "blind" by two independent observers. Interstitial haemorrhage was more common in patients treated with azathioprine and prednisolone corresponding with their poorer graft survival. Analysis of glomerular, tubular, vascular, and interstitial changes showed no other important differences between the two groups despite clinical evidence of reversible cyclosporin nephrotoxicity. Quantitation of interstitial fibrosis in 90 day biopsies showed it to be equal in prevalence after treatment with azathioprine and prednisolone and cyclosporin. It was preceded by diffuse interstitial cellular infiltration, a common finding in early biopsies. Diffuse cellular infiltrates were generally associated with higher serum creatinine concentrations and, if persistent, a poorer graft prognosis than focal infiltrates, but they were not always associated with renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512612      PMCID: PMC499668          DOI: 10.1136/jcp.39.2.145

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Percutaneous needle biopsies of renal allografts: the relationship between morphological changes present in biopsies and subsequent allograft function.

Authors:  B M Herbertson; D B Evans; R Y Calne; A K Banerjee
Journal:  Histopathology       Date:  1977-05       Impact factor: 5.087

2.  Cyclosporine nephrotoxicity.

Authors:  W M Bennett; J P Pulliam
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

3.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

4.  Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

5.  Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin.

Authors:  A Farnsworth; B M Hall; A B Ng; G G Duggin; J S Horvath; A G Sheil; D J Tiller
Journal:  Am J Surg Pathol       Date:  1984-04       Impact factor: 6.394

6.  Cyclosporin A in cadaveric organ transplantation.

Authors:  R Y Calne; D J White; D B Evans; S Thiru; R G Henderson; D V Hamilton; K Rolles; P McMaster; T J Duffy; B R MacDougall; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

7.  Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.

Authors:  R K Sibley; J Rynasiewicz; R M Ferguson; D Fryd; D E Sutherland; R L Simmons; J S Najarian
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

8.  Glomerular thrombi in renal allografts associated with cyclosporin treatment.

Authors:  G H Neild; R Reuben; R B Hartley; J S Cameron
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

9.  Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.

Authors:  R L Powles; H M Clink; D Spence; G Morgenstern; J G Watson; P J Selby; M Woods; A Barrett; B Jameson; J Sloane; S D Lawler; H E Kay; D Lawson; T J McElwain; P Alexander
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

10.  Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury.

Authors:  H Shulman; G Striker; H J Deeg; M Kennedy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

View more
  9 in total

Review 1.  Is it time to give up with calcineurin inhibitors in kidney transplantation?

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2013-06-24

2.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

3.  Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and nonrejecting heart allografts.

Authors:  B M Spriewald; M Hara; A Bushell; S Jenkins; P J Morris; K J Wood
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

4.  Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.

Authors:  J R Pratt; M J Hibbs; A J Laver; R A Smith; S H Sacks
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

5.  Renal allograft rejection in children and young adults: the Banff classification.

Authors:  H E Corey; S M Greenstein; V Tellis; R Schechner; I Greifer; B Bennett
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

6.  Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform.

Authors:  S M Kurian; E Velazquez; R Thompson; T Whisenant; S Rose; N Riley; F Harrison; T Gelbart; J J Friedewald; J Charette; S Brietigam; J Peysakhovich; M R First; M M Abecassis; D R Salomon
Journal:  Am J Transplant       Date:  2017-04-03       Impact factor: 8.086

7.  Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation.

Authors:  Ozan Ekmekçioğlu; Sadi Turkan; Şener Yıldız; Zeki Ender Güneş
Journal:  Turk J Urol       Date:  2013-03

8.  An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis.

Authors:  R Shapiro; P Randhawa; M L Jordan; V P Scantlebury; C Vivas; A Jain; R J Corry; J McCauley; J Johnston; J Donaldson; E A Gray; I Dvorchik; T R Hakala; J J Fung; T E Starzl
Journal:  Am J Transplant       Date:  2001-05       Impact factor: 8.086

9.  Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants.

Authors:  D J Versluis; F J Ten Kate; G J Wenting; J Jeekel; W Weimar
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.